MDPI and ACS Style
Teijeira, L.; MartÃnez, M.; Moreno, A.; de Elejoste, I.; Ibáñez-Beroiz, B.; Arrazubi, V.; DÃaz de Corcuera, I.; Elejalde, I.; Campillo-Calatayud, A.; Les, I.
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective. Cancers 2024, 16, 151.
https://doi.org/10.3390/cancers16010151
AMA Style
Teijeira L, MartÃnez M, Moreno A, de Elejoste I, Ibáñez-Beroiz B, Arrazubi V, DÃaz de Corcuera I, Elejalde I, Campillo-Calatayud A, Les I.
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective. Cancers. 2024; 16(1):151.
https://doi.org/10.3390/cancers16010151
Chicago/Turabian Style
Teijeira, LucÃa, Mireia MartÃnez, Amaia Moreno, Ibone de Elejoste, Berta Ibáñez-Beroiz, Virginia Arrazubi, Isabela DÃaz de Corcuera, Iñaki Elejalde, Ana Campillo-Calatayud, and Iñigo Les.
2024. "Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective" Cancers 16, no. 1: 151.
https://doi.org/10.3390/cancers16010151
